{"id":"https://openalex.org/W4362534871","doi":"https://doi.org/10.1158/1535-7163.22506573.v1","title":"Supplementary Figure legends S1-3 from Efficient Payload Delivery by a Bispecific Antibody\u2013Drug Conjugate Targeting HER2 and CD63","display_name":"Supplementary Figure legends S1-3 from Efficient Payload Delivery by a Bispecific Antibody\u2013Drug Conjugate Targeting HER2 and CD63","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362534871","doi":"https://doi.org/10.1158/1535-7163.22506573.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22506573.v1","doi":"https://doi.org/10.1158/1535-7163.22506573.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22506573.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.22506573.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081340725","display_name":"Bart E.C.G. de Goeij","orcid":"https://orcid.org/0000-0002-8093-238X","observed_orcids":["https://orcid.org/0000-0002-8093-238X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bart E.C.G. de Goeij","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077529516","display_name":"Tom Vink","orcid":"https://orcid.org/0000-0001-6205-1733","observed_orcids":["https://orcid.org/0000-0001-6205-1733"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tom Vink","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032677714","display_name":"Hendrik ten Napel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hendrik ten Napel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014666198","display_name":"Esther C.W. Breij","orcid":"https://orcid.org/0000-0002-5368-6849","observed_orcids":["https://orcid.org/0000-0002-5368-6849"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Esther C.W. Breij","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108434362","display_name":"David P. E. Satijn","orcid":"https://orcid.org/0009-0006-2026-3360","observed_orcids":["https://orcid.org/0009-0006-2026-3360"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Satijn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045676857","display_name":"Richard Wubbolts","orcid":"https://orcid.org/0000-0001-8661-7594","observed_orcids":["https://orcid.org/0000-0001-8661-7594"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Wubbolts","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009908374","display_name":"David Miao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Miao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5039190287","display_name":"Paul W.H.I. Parren","orcid":"https://orcid.org/0000-0002-4365-3859","observed_orcids":["https://orcid.org/0000-0002-4365-3859"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul W.H.I. Parren","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.2639000117778778,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.2639000117778778,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.25119999051094055,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.23319999873638153,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bispecific-antibody-drug-conjugate","display_name":"bispecific antibody-drug conjugate","score":0.9700000286102295},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.9900000095367432},{"id":"https://openalex.org/keywords/cd63","display_name":"CD63","score":1.0},{"id":"https://openalex.org/keywords/payload-delivery","display_name":"payload delivery","score":0.9279999732971191},{"id":"https://openalex.org/keywords/targeted-drug-delivery","display_name":"targeted drug delivery","score":0.6010000109672546}],"concepts":[{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.8452052474021912},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.7865661382675171},{"id":"https://openalex.org/C134066672","wikidata":"https://www.wikidata.org/wiki/Q1424639","display_name":"Payload (computing)","level":3,"score":0.6664386987686157},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.5720430612564087},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4908216893672943},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.45762619376182556},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4509737193584442},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.32262080907821655},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.31990644335746765},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.26856356859207153},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.25729718804359436},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.18449988961219788},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.17287787795066833},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.13715630769729614},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.07894787192344666},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.06229642033576965},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0},{"id":"https://openalex.org/C158379750","wikidata":"https://www.wikidata.org/wiki/Q214111","display_name":"Network packet","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.22506573.v1","doi":"https://doi.org/10.1158/1535-7163.22506573.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22506573.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22506573","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_legends_S1-3_from_Efficient_Payload_Delivery_by_a_Bispecific_Antibody_Drug_Conjugate_Targeting_HER2_and_CD63/22506573","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22506573.v1","doi":"https://doi.org/10.1158/1535-7163.22506573.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22506573.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2513494897","https://openalex.org/W4362493135","https://openalex.org/W7162752096","https://openalex.org/W4241867273","https://openalex.org/W4407145603","https://openalex.org/W4394716438","https://openalex.org/W7166714750","https://openalex.org/W4362624898"],"abstract_inverted_index":{"Supplementary":[0],"Figure":[1],"legends":[2],"for":[3],"figures":[4],"S1,":[5],"S2":[6],"and":[7],"S3":[8]},"counts_by_year":[],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2023-04-06T00:00:00"}